Gien that the good effect among cancer patients, these approach, The adoptive cell transfer therapy combining DC vaccination with ex vivo Cbl-b silencing has successfully slowed the growth of tumor cells, and a Phase I clinical trial (NCT03087591) has been initiated. This evidence concerns the gene CBLB and neoplasm.